Adverse effects of molgramostim in marrow transplant recipients.
Ippoliti
C
C
University of Texas M.D. Anderson Cancer Center, Division of Pharmacy, Houston 77030.
Przepiorka
D
D
Smith
T
T
Maiese
S
S
Giralt
S
S
Andersson
B S
BS
Deisseroth
A B
AB
Champlin
R E
RE
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000379:methods; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012189:Retrospective Studies; D012307:Risk Factors
D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; C082430:molgramostim